Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Lumicks Ca Holding B V currently manages a focused patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio shows a highly concentrated prosecution strategy, as evidenced by the presence of only 1 pending office action. This matter is distributed across 1 distinct examiner and 1 distinct art unit, indicating a narrow scope of current USPTO engagement.
The busiest examiner for the company is KELLY, ROBERT M, who is responsible for the pending matter currently on record. This examiner's workload represents the entirety of the company's active prosecution pipeline. Because the busiest examiner pending count is 1, there is no internal competition for resources or attention across different examiners for this entity.
The alignment of the 1 distinct examiner with the 1 distinct art unit suggests that the company's current legal efforts are localized within a specific technical niche. Practitioners can expect a streamlined communication path, as all active matters reside with a single individual. This concentration simplifies the management of deadlines and examiner interviews for the outstanding office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KELLY, ROBERT M | 1 | 74.1% | +24.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18725439 | SELECTING FORCES FOR MEANS AND METHODS INVOLVING CELLULAR AVIDITY | KELLY, ROBERT M | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18725439 | SELECTING FORCES FOR MEANS AND METHODS INVOLVING CELLULAR AVIDITY | KELLY, ROBERT M | 1657 | §112 | Non-Final OA | — | Pending | Jun 28, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial